WHO ICTRP trial
pilot study of systemic combination therapy with TS-1 and IFN for hepatocellular…
JPRN-UMIN000002929 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000002929 |
|---|---|
| Public title | pilot study of systemic combination therapy with TS-1 and IFN for hepatocellular carcinoma patients with extrahepatic metastases who do not response to systemic combination therapy with TS-1 and cisplatin. |
| Scientific title | pilot study of systemic combination therapy with TS-1 and IFN for hepatocellular carcinoma patients with extrahepatic metastases who do not response to systemic combination therapy with TS-1 and cisplatin. - TS-1/IFN for HCC patients with metastases who do not response to TS-1/CDDP |
| Primary sponsor | Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical, Hiroshima University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | hepatocellular carcinoma with extrahepatic metastases |
| Interventions | Two weeks represented one cycle of treatment. In each cycle, S-1 was administered orally at a dose of 80-120 mg daily (depending on body surface area: <1.25 m2, 80 mg; 1.25-1.5 m2, 100 mg; ≥1.5 m2, 120 mg), and CDDP was administered… |
| Registration date | Dec 22, 2009 |
| Target size | 10 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: